Company intelligence
Altimmune, Inc.
Late clinical-stage biotech working to improve the lives of those living with serious liver diseases
Biotechnology Research
Gaithersburg, US
89 employees
Founded 1997
1 public signals
About Altimmune, Inc.
Altimmune is a late clinical-stage biopharmaceutical company developing therapies to improve the lives of people living with serious liver diseases. Our lead program is a differentiated dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio, currently in development for metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). #ClinicalResearch #LiverCare #BioResearch
Verified activity
Signals from Altimmune, Inc.
1 published signal